Array BioPharma (ARRY) Posts Mixed Q3 Results
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $4.71 --0%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Array BioPharma, Inc. (Nasdaq: ARRY) reported Q3 loss of $0.20, $0.05 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $17.8 million versus the consensus estimate of $19.58 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ARRAY Technologies to Detail Balance-of-System Strategy and APA Long-Term Growth Opportunities at the APA Investor Technology Showcase Today
- Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
